Statin dose in primary prevention: aim for the target!

被引：6

作者：

Bittencourt, Marcio S. ^{[1
,2
]}

Cesena, Fernando H. Y. ^{[3
]}

机构：

[1] Univ Hosp, Div Internal Med, BR-2565 Sao Paulo, SP, Brazil

[2] Brigham & Womens Hosp, Dept Internal Med, 75 Francis St, Boston, MA 02115 USA

[3] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil

来源：

HEART | 2019年 / 105卷 / 13期

关键词：

risk factors; statins; primary prevention; cardiovascular disease; GUIDELINES;

D O I：

10.1136/heartjnl-2019-314723

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：969 / 971

页数：3

共 8 条

[1] Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease [J].

Akyea, Ralph Kwame ;

Kai, Joe ;

Qureshi, Nadeem ;

Iyen, Barbara ;

Weng, Stephen F. .

HEART, 2019, 105 (13) :975-+

[2] 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) [J].

Catapano, Alberico L. ;

Graham, Ian ;

De Backer, Guy ;

Wiklund, Olov ;

Chapman, M. John ;

Drexel, Heinz ;

Hoes, Arno W. ;

Jennings, Catriona S. ;

Landmesser, Ulf ;

Pedersen, Terje R. ;

Reiner, Zeljko ;

Riccardi, Gabriele ;

Taskinen, Marja-Riita ;

Tokgozoglu, Lale ;

Verschuren, W. M. Monique ;

Vlachopoulos, Charalambos ;

Wood, David A. ;

Luis Zamorano, Jose .

ATHEROSCLEROSIS, 2016, 253 :281-344

[3] Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS) [J].

Danchin, Nicolas ;

Almahmeed, Wael ;

Al-Rasadi, Khalid ;

Azuri, Joseph ;

Berrah, Abdelkrim ;

Cuneo, Carlos Alberto ;

Karpov, Yuri ;

Kaul, Upendra ;

Kayikcioglu, Meral ;

Mitchenko, Olena ;

Ruiz, Alvaro J. ;

Salinas, Carlos A. Aguilar ;

Santos, Raul D. ;

Mercier, Florence ;

Blom, Dirk .

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2018, 25 (10) :1087-1094

[4]

Excellence NIfHaC, 2016, CARD DIS RISK ASS RE

[5] 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [J].

Grundy, Scott M. ;

Stone, Neil J. ;

Bailey, Alison L. ;

Beam, Craig ;

Birtcher, Kim K. ;

Blumenthal, Roger S. ;

Braun, Lynne T. ;

de Ferranti, Sarah ;

Faiella-Tommasino, Joseph ;

Forman, Daniel E. ;

Goldberg, Ronald ;

Heidenreich, Paul A. ;

Hlatky, Mark A. ;

Jones, Daniel W. ;

Lloyd-Jones, Donald ;

Lopez-Pajares, Nuria ;

Ndumele, Chiadi E. ;

Orringer, Carl E. ;

Peralta, Carmen A. ;

Saseen, Joseph J. ;

Smith, Sidney C., Jr. ;

Sperling, Laurence ;

Virani, Salim S. ;

Yeboah, Joseph .

CIRCULATION, 2019, 139 (25) :E1082-E1143

[6] Comparison of Five Major Guidelines for Statin Use in Primary Prevention in a Contemporary General Population [J].

Mortensen, Martin Bodtker ;

Nordestgaard, Borge Gronne .

ANNALS OF INTERNAL MEDICINE, 2018, 168 (02) :85-+

[7] Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering A Systematic Review and Meta-analysis [J].

Navarese, Eliano P. ;

Robinson, Jennifer G. ;

Kowalewski, Mariusz ;

Kolodziejczak, Michalina ;

Andreotti, Felicita ;

Bliden, Kevin ;

Tantry, Udaya ;

Kubica, Jacek ;

Raggi, Paolo ;

Gurbel, Paul A. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (15) :1566-1579

[8] Cholesterol, not just cardiovascular risk, is important in deciding who should receive statin treatment [J].

Soran, Handrean ;

Schofield, Jonathan D. ;

Durrington, Paul N. .

EUROPEAN HEART JOURNAL, 2015, 36 (43) :2975-2983

← 1 →